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Abstract
Case report: A 25-year-old man with Behc¸et’s disease was admitted because of weakness of the lower
limbs and difficulty in urination. He had received a rabies vaccination 2 months previous because he had
been bitten by a dog.
Findings: Clinical and laboratory findings supported acute transverse myelitis. A hyperintense lesion and
expansion at the level of conus medullaris was detected on spinal magnetic resonance imaging.
Conclusion: Although neurologic involvement is one of the main causes of mortality and morbidity in
Behc¸et’s disease, the factors that aggravate the involvement of the nervous system are still unclear. Vaccination
may have been the factor that had activated autoimmune mechanisms in this case. To our knowledge,
involvement of the conus medullaris in Behc¸et’s disease after rabies vaccination has not been reported.
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INTRODUCTION
Transverse myelitis is a clinical syndrome that involves the
spinal cord, resulting in varying degrees of weakness,
sensory alterations, and autonomic dysfunction (1).
Acute transverse myelitis (ATM) can be due to post-
infectious immune-mediated inflammation of the spinal
cord (2). Active or passive immunization with vaccines or
sera can cause lesions with immunomediated pathogen-
esis and may involve both the central and the peripheral
nervous system (3). Vaccination as an etiology of ATM is
frequently reported, but the involvement of the conus
medullaris after vaccination has been reported in only
one case (4).
Behc¸et’s disease is a well-known multisystemic
vasculitis, but the etiology is still not well understood.
Some factors (eg, autoimmunity, infections, heredity,
environmental factors) have been frequently described in
the etiopathogenesis (5), but only one case of Behc¸et’s
disease triggered by vaccination has been reported
previously (6). The neurological involvement in Behc¸et’s
disease is well known, but myelitis is rare, especially when
it is the only neurological manifestation (7). The factors
causing or activating the neurological involvement in
Behc¸et’s disease are still not clear. We report a patient
with Behc¸et’s disease presenting with a conus medullaris
lesion in whom the involvement may be associated with
rabies vaccination.
CASE REPORT
A 25-year-old man with Behc¸et’s disease was admitted
because of weakness of his lower limbs and urinary
retention. He had a severe backache for 12 hours before
the onset of lower-limb weakness. His weakness progres-
sively worsened, and he began experiencing difficulty
with urination and defecation. He had received a rabies
vaccination 2 months earlier after being bit by a dog.
Rabipur (active substance: inactivated rabies virus) was
administered on the day of the bite and on the 3rd and
7th days thereafter. Past medical history revealed that he
had recurrent aphthous stomatitis and genital ulcerations
beginning at age 13 years. He had been diagnosed with
Behc¸et’s disease when he was 20 years old. The pathergy
test was positive. He also had an attack of deep-venous
thrombosis 2 years previous.
On physical examination, a few papulopustular
lesions inside the thighs and genital ulceration were
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found. His muscle strength was 2/5 at his proximal left
lower limb, 1/5 at his distal left lower limb, 3/5 at his
proximal right lower limb, and 1/5 at his distal right
lower limb in Medical Research Council grade. There was
hypoesthesia below the level of L1, and his vibratory and
position senses were absent in his lower extremities.
Deep tendon reflexes were absent in the lower extrem-
ities, and plantar responses were extensor bilaterally. The
remainder of the neurological examination was normal.
Diagnostic Workup
Complete blood count, biochemistry, and sedimentation
rate were normal. Serum hepatitis markers, anti–human
immunodeficiency virus (HIV) antibody (Ab), Brucella
agglutination test, Venereal Disease Research Laboratory
test, varicella zoster virus (VZV) Ab, and Toxoplasma Ab
were negative. Markers of vasculitis, including the
autoantibodies SS-A, SS-B, anti-nuclear antibody (ANA),
and anti-DNA, were negative.
The patient’s cerebrospinal fluid (CSF) was macro-
scopically clear; microscopic examination showed 110
leucocytes/mm3, and no microorganisms were found.
The CSF protein level was elevated (114 mg/dL), glucose
level was 44 mg/dL, and simultaneous serum glucose
level was 70 mg/dL. Oligoclonal banding was not found
in the CSF, and the CSF IgG index was 0.59 (N , 0.66).
Total Toxoplasma Ab, cytomegalovirus (CMV) IgM and
IgG Ab, herpes simplex virus (HSV) types I and II IgM,
and HSV types I and II IgG Ab were negative in CSF.
Magnetic resonance imaging (MRI) of the cranium was
normal. A hyperintense lesion and expansion at the level
of the conus medullaris was detected in his spinal MRI
(Figure 1). It was Gd(t). Computed tomographic
angiography of the vascular structures, cardiology
consultation, echocardiography, and hematological in-
vestigations were performed in detail, and all were in
normal limits.
After hospitalization, pulse steroid therapy of 1g/d for
5 days was started. After pulse methylprednisolone
therapy was switched to oral form and dosages were
decreased slowly, azathioprine 150 mg/d was added to
his treatment and continued for long-term therapy.
The patient underwent regular physiotherapy, and
after 1 month his muscle strength was 3þ/5 in his left
lower limb and 4/5 in his right lower limb. Atrophy and
fasciculations were seen, especially in his left leg muscles
innervated by L5-S1. There was hypoesthesia below level
L3. His vibratory and position senses and deep tendon
reflexes were absent at his lower extremities. Plantar
responses were extensor bilaterally. The patient was
transferred to a physiotherapy center. Urinary retention
and detrusor atony were detected in urodynamic studies.
He needed intermittent catheterization for 4 months.
One year later, his complaints and pathologic findings
had completely resolved. Control spinal MRI was normal
(Figure 2).
DISCUSSION
The neurological complications of Behc¸et’s disease are
observed in 5 to 35% of all cases, depending on the series
(8). Tohme et al (9) studied central nervous system and
peripheral nervous system involvement in Behc¸et’s
disease, and they found that meningoencephalitis and/or
transverse myelitis were the most frequent features (69%)
followed by tumor-like manifestations (13%). However,
transverse myelitis is rare, especially as a sole clinical
manifestation (8). This patient’s diagnosis of Behc¸et’s
disease was confirmed at our clinic, and he had only ATM
as the presenting neurological manifestation.
Acute transverse myelitis is an inflammatory disorder.
The pathogenesis is unclear, but the probable mecha-
nism involves an autoimmune phenomenon. Possible
causes include parainfectious and postvaccination events;
ATM also can be seen in the course of multiple sclerosis
(10). Das et al (11) reported the etiologies of transverse
myelitis or myelopathy and found the following: 29.26%
postinfectious, 19.51% demyelination, 3.65% vascular
and vasculitis, 1.21% toxic, and 2.42% physical. They also
reported a vaccination history in 1.21% of their patients,
as in this case, in which a rabies vaccination was given 2
months prior to the onset of neurological symptoms.
Figure 1. Initial spinal magnetic resonance image
showing a hyperintense lesion and expansion at the level
of the conus medullaris (T2W).
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Acute transverse myelitis may be an isolated entity or
may occur in the context of a multifocal or even a
multisystemic disease (12). In this case, 2 different factors
(Behc¸et’s disease and vaccination) may explain the
etiology of ATM. Carod-Artal et al (13) and Olson et al
(14) reported cases with myelopathy at the level of the
conus medullaris due to Schistosomia mansoni. Longitu-
dinal involvement of the spinal cord including the conus
medullaris level due to systemic lupus erythematosus-
related transverse myelitis has been reported (15,16).
However, it has not been reported with Behc¸et’s disease
or after rabies vaccination. Only one case with isolated
myelitis of the conus medullaris due to vaccination
against tetanus-poliomyelitis was reported by Abdennebi
et al (4).
Although neurologic involvement is one of the main
causes of mortality and morbidity in Behc¸et’s disease, the
factors that aggravate the involvement of the nervous
system are still unclear. In this case, vaccination may be
the factor that activated autoimmune mechanisms and
may have caused the neurological involvement. There
have been no controlled drug trials for treatment of
Neuro-Behc¸et syndrome, but steroids and immunosup-
pressive can be beneficial.
CONCLUSION
Involvement of the conus medullaris in Behc¸et’s disease
after rabies vaccination has not been reported previously
in the literature. The possibility of an activating factor (eg,
vaccination) other than infection has never been
mentioned in Neuro-Behc¸et syndrome. Understanding
the activating factors may be helpful for the prevention of
neurological involvement and is important for planning
follow up and understanding the prognosis. Further
reports and investigations are needed.
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Figure 2. Follow-up spinal magnetic resonance image
showing resolution, taken 1 year later when symptoms
had resolved.
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